# Biofourmis
> Biofourmis provides an end-to-end platform for AI-driven in-home care, addressing challenges across the continuum from care delivery to clinical trials (though Life Science business recently acquired by ActiGraph). Their technology-enabled solutions empower patients to receive care at home and transition between care levels, demonstrating significant clinical, operational, and economic improvements.
- URL: https://optimly.ai/brand/biofourmis
- Logo: https://logo.clearbit.com/https://biofourmis.com/
- Slug: biofourmis
- BAI Score: 50/100
- Archetype: Challenger
- Category: Healthcare Technology
- Last Analyzed: July 19, 2026
## Buyer Intent Signals
Problems: Traditional In-Hospital Care: Patients receive all care within a hospital setting, requiring physical presence for monitoring and treatment, lacking the convenience and potential cost savings of home- | Conventional Home Health Agencies: Home care services provided by nurses and aides without advanced remote monitoring technology or AI-driven insights, leading to less proactive care and higher relian | Status Quo Healthcare Delivery: Continuing with existing healthcare models that lead to high readmission rates, delayed detection of patient deterioration, and escalating costs, without leveraging tec
Solutions: Biofourmis AI home care | Biofourmis remote patient monitoring | Hospital at Home solutions Biofourmis | Biofourmis merger CopilotIQ | Biofourmis clinical outcomes | Standalone Remote Monitoring Devices: Using basic wearable sensors or health devices that collect data but lack an integrated AI platform for predictive analytics, personalized care pathways, or seaml